{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:39:50Z","timestamp":1792719590771,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,9,7]],"date-time":"2012-09-07T00:00:00Z","timestamp":1346976000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1741-7015-10-101","type":"journal-article","created":{"date-parts":[[2012,9,7]],"date-time":"2012-09-07T14:14:48Z","timestamp":1347027288000},"source":"Crossref","is-referenced-by-count":59,"title":["Transforming growth factor \u03b21 inhibits bone morphogenic protein (BMP)-2 and BMP-7 signaling via upregulation of Ski-related novel protein N (SnoN): possible mechanism for the failure of BMP therapy?"],"prefix":"10.1186","volume":"10","author":[{"given":"Sabrina","family":"Ehnert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Pscherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Freude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Dooley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"St\u00f6ckle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas Klaus","family":"Nussler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,7]]},"reference":[{"key":"610_CR1","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nbt0398-247","volume":"16","author":"AH Reddi","year":"1998","unstructured":"Reddi AH: Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechnol. 1998, 16: 247-252. 10.1038\/nbt0398-247.","journal-title":"Nat Biotechnol"},{"key":"610_CR2","first-page":"1219","volume":"28","author":"DS Baskin","year":"2003","unstructured":"Baskin DS, Ryan P, Sonntag V, Westmark R, Widmayer MA: A prospective, randomized, controlled cervical fusion study using recombinant human bone morphogenetic protein-2 with the CORNERSTONE-SR allograft ring and the ATLANTIS anterior cervical plate. Spine (Phila Pa 1976). 2003, 28: 1219-1224.","journal-title":"Spine (Phila Pa 1976)"},{"key":"610_CR3","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.2106\/JBJS.G.01485","volume":"91","author":"JK Burkus","year":"2009","unstructured":"Burkus JK, Gornet MF, Schuler TC, Kleeman TJ, Zdeblick TA: Six-year outcomes of anterior lumbar interbody arthrodesis with use of interbody fusion cages and recombinant human bone morphogenetic protein-2. J Bone Joint Surg Am. 2009, 91: 1181-1189. 10.2106\/JBJS.G.01485.","journal-title":"J Bone Joint Surg Am"},{"key":"610_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/BSD.0b013e31817d8161","volume":"22","author":"PT Geibel","year":"2009","unstructured":"Geibel PT, Boyd DL, Slabisak V: The use of recombinant human bone morphogenic protein in posterior interbody fusions of the lumbar spine: a clinical series. J Spinal Disord Tech. 2009, 22: 315-320. 10.1097\/BSD.0b013e31817d8161.","journal-title":"J Spinal Disord Tech"},{"key":"610_CR5","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1097\/BRS.0b013e31818a314d","volume":"33","author":"AR Vaccaro","year":"2008","unstructured":"Vaccaro AR, Lawrence JP, Patel T, Katz LD, Anderson DG, Fischgrund JS, Krop J, Fehlings MG, Wong D: The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft in posterolateral lumbar arthrodesis: a long-term (> 4 years) pivotal study. Spine (Phila Pa 1976). 2008, 33: 2850-2862. 10.1097\/BRS.0b013e31818a314d.","journal-title":"Spine (Phila Pa 1976)"},{"key":"610_CR6","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00264-007-0422-x","volume":"31","author":"AP White","year":"2007","unstructured":"White AP, Vaccaro AR, Hall JA, Whang PG, Friel BC, McKee MD: Clinical applications of BMP-7\/OP-1 in fractures, nonunions and spinal fusion. Int Orthop. 2007, 31: 735-741. 10.1007\/s00264-007-0422-x.","journal-title":"Int Orthop"},{"key":"610_CR7","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00264-006-0235-3","volume":"31","author":"LD Wu","year":"2007","unstructured":"Wu LD, Xiong Y, Yu HC: Effects of rhBMP-2 on cortical strut allograft healing to the femur in revision total hip arthroplasties: an experimental study. Int Orthop. 2007, 31: 605-611. 10.1007\/s00264-006-0235-3.","journal-title":"Int Orthop"},{"key":"610_CR8","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.jocn.2009.02.012","volume":"16","author":"J Leach","year":"2009","unstructured":"Leach J, Bittar RG: BMP-7 (OP-1) safety in anterior cervical fusion surgery. J Clin Neurosci. 2009, 16: 1417-1420. 10.1016\/j.jocn.2009.02.012.","journal-title":"J Clin Neurosci"},{"issue":"Suppl 3","key":"610_CR9","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1016\/S0020-1383(09)70009-9","volume":"40","author":"AL Shimer","year":"2009","unstructured":"Shimer AL, Oner FC, Vaccaro AR: Spinal reconstruction and bone morphogenetic proteins: open questions. Injury. 2009, 40 (Suppl 3): S32-38.","journal-title":"Injury"},{"key":"610_CR10","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1093\/ndt\/gfr324","volume":"26","author":"H Koppel","year":"2011","unstructured":"Koppel H, Riedl E, Braunagel M, Sauerhoefer S, Ehnert S, Godoy P, Sternik P, Dooley S, Yard BA: L-carnosine inhibits high-glucose-mediated matrix accumulation in human mesangial cells by interfering with TGF-{beta} production and signalling. Nephrol Dial Transplant. 2011, 26: 3852-3858. 10.1093\/ndt\/gfr324.","journal-title":"Nephrol Dial Transplant"},{"key":"610_CR11","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/jcb.240550312","volume":"55","author":"LF Bonewald","year":"1994","unstructured":"Bonewald LF, Dallas SL: Role of active and latent transforming growth factor beta in bone formation. J Cell Biochem. 1994, 55: 350-357. 10.1002\/jcb.240550312.","journal-title":"J Cell Biochem"},{"key":"610_CR12","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","volume":"113","author":"Y Shi","year":"2003","unstructured":"Shi Y, Massague J: Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003, 113: 685-700. 10.1016\/S0092-8674(03)00432-X.","journal-title":"Cell"},{"key":"610_CR13","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1359\/jbmr.060810","volume":"21","author":"DL Ellies","year":"2006","unstructured":"Ellies DL, Viviano B, McCarthy J, Rey JP, Itasaki N, Saunders S, Krumlauf R: Bone density ligand, sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity. J Bone Miner Res. 2006, 21: 1738-1749. 10.1359\/jbmr.060810.","journal-title":"J Bone Miner Res"},{"key":"610_CR14","doi-asserted-by":"publisher","first-page":"e14073","DOI":"10.1371\/journal.pone.0014073","volume":"5","author":"S Ehnert","year":"2010","unstructured":"Ehnert S, Baur J, Schmitt A, Neumaier M, Lucke M, Dooley S, Vester H, Wildemann B, Stockle U, Nussler AK: TGF-beta1 as possible link between loss of bone mineral density and chronic inflammation. PLoS One. 2010, 5: e14073-10.1371\/journal.pone.0014073.","journal-title":"PLoS One"},{"key":"610_CR15","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1056\/NEJM199411103311907","volume":"331","author":"WA Border","year":"1994","unstructured":"Border WA, Noble NA: Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994, 331: 1286-1292. 10.1056\/NEJM199411103311907.","journal-title":"N Engl J Med"},{"key":"610_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.cardiores.2006.07.012","volume":"74","author":"A Leask","year":"2007","unstructured":"Leask A: TGFbeta, cardiac fibroblasts, and the fibrotic response. Cardiovasc Res. 2007, 74: 207-212. 10.1016\/j.cardiores.2006.07.012.","journal-title":"Cardiovasc Res"},{"key":"610_CR17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem. 1951, 193: 265-275.","journal-title":"J Biol Chem"},{"key":"610_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S8756-3282(98)00078-7","volume":"23","author":"AG Geiser","year":"1998","unstructured":"Geiser AG, Zeng QQ, Sato M, Helvering LM, Hirano T, Turner CH: Decreased bone mass and bone elasticity in mice lacking the transforming growth factor-beta1 gene. Bone. 1998, 23: 87-93. 10.1016\/S8756-3282(98)00078-7.","journal-title":"Bone"},{"key":"610_CR19","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1083\/jcb.110.6.2195","volume":"110","author":"ME Joyce","year":"1990","unstructured":"Joyce ME, Roberts AB, Sporn MB, Bolander ME: Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur. J Cell Biol. 1990, 110: 2195-2207. 10.1083\/jcb.110.6.2195.","journal-title":"J Cell Biol"},{"key":"610_CR20","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1210\/endo-124-6-2991","volume":"124","author":"M Noda","year":"1989","unstructured":"Noda M, Camilliere JJ: In vivo stimulation of bone formation by transforming growth factor-beta. Endocrinology. 1989, 124: 2991-2994. 10.1210\/endo-124-6-2991.","journal-title":"Endocrinology"},{"key":"610_CR21","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/8756-3282(94)90300-X","volume":"15","author":"D Rosen","year":"1994","unstructured":"Rosen D, Miller SC, DeLeon E, Thompson AY, Bentz H, Mathews M, Adams S: Systemic administration of recombinant transforming growth factor beta 2 (rTGF-beta 2) stimulates parameters of cancellous bone formation in juvenile and adult rats. Bone. 1994, 15: 355-359. 10.1016\/8756-3282(94)90300-X.","journal-title":"Bone"},{"key":"610_CR22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1083\/jcb.132.1.195","volume":"132","author":"A Erlebacher","year":"1996","unstructured":"Erlebacher A, Derynck R: Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype. J Cell Biol. 1996, 132: 195-210. 10.1083\/jcb.132.1.195.","journal-title":"J Cell Biol"},{"key":"610_CR23","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1242\/dev.126.19.4267","volume":"126","author":"E Filvaroff","year":"1999","unstructured":"Filvaroff E, Erlebacher A, Ye J, Gitelman SE, Lotz J, Heillman M, Derynck R: Inhibition of TGF-beta receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass. Development. 1999, 126: 4267-4279.","journal-title":"Development"},{"key":"610_CR24","doi-asserted-by":"publisher","first-page":"e5275","DOI":"10.1371\/journal.pone.0005275","volume":"4","author":"KS Mohammad","year":"2009","unstructured":"Mohammad KS, Chen CG, Balooch G, Stebbins E, McKenna CR, Davis H, Niewolna M, Peng XH, Nguyen DH, Ionova-Martin SS, Bracey JW, Hogue WR, Wong DH, Ritchie RO, Suva LJ, Derynck R, Guise TA, Alliston T: Pharmacologic inhibition of the TGF-beta type I receptor kinase has anabolic and anti-catabolic effects on bone. PLoS One. 2009, 4: e5275-10.1371\/journal.pone.0005275.","journal-title":"PLoS One"},{"key":"610_CR25","doi-asserted-by":"publisher","first-page":"23200","DOI":"10.1074\/jbc.M311998200","volume":"279","author":"S Wang","year":"2004","unstructured":"Wang S, Hirschberg R: Bone morphogenetic protein-7 signals opposing transforming growth factor beta in mesangial cells. J Biol Chem. 2004, 279: 23200-23206. 10.1074\/jbc.M311998200.","journal-title":"J Biol Chem"},{"key":"610_CR26","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1074\/jbc.C200596200","volume":"278","author":"M Mizuide","year":"2003","unstructured":"Mizuide M, Hara T, Furuya T, Takeda M, Kusanagi K, Inada Y, Mori M, Imamura T, Miyazawa K, Miyazono K: Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN. J Biol Chem. 2003, 278: 531-536.","journal-title":"J Biol Chem"},{"key":"610_CR27","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","volume":"10","author":"W Balemans","year":"2001","unstructured":"Balemans W, Ebeling M, Patel N, Van Hul E, Olson P, Dioszegi M, Lacza C, Wuyts W, Van Den Ende J, Willems P, Paes-Alves AF, Hill S, Bueno M, Ramos FJ, Tacconi P, Dikkers FG, Stratakis C, Lindpaintner K, Vickery B, Foernzler D, Van Hul W: Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet. 2001, 10: 537-543. 10.1093\/hmg\/10.5.537.","journal-title":"Hum Mol Genet"},{"key":"610_CR28","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1172\/JCI15543","volume":"112","author":"XB Wu","year":"2003","unstructured":"Wu XB, Li Y, Schneider A, Yu W, Rajendren G, Iqbal J, Yamamoto M, Alam M, Brunet LJ, Blair HC, Zaidi M, Abe E: Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice. J Clin Invest. 2003, 112: 924-934.","journal-title":"J Clin Invest"},{"key":"610_CR29","first-page":"85","volume":"9","author":"MC Machado","year":"2010","unstructured":"Machado MC, Bellodi-Privato M, Kubrusly MS, Molan NA, Tharcisio T, de Oliveira ER, D'Albuquerque LA: Valproic acid inhibits human hepatocellular cancer cells growth in vitro and in vivo. J Exp Ther Oncol. 2010, 9: 85-92.","journal-title":"J Exp Ther Oncol"},{"key":"610_CR30","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1016\/j.jprot.2011.06.016","volume":"74","author":"DY Ouyang","year":"2011","unstructured":"Ouyang DY, Ji YH, Saltis M, Xu LH, Zhang YT, Zha QB, Cai JY, He XH: Valproic acid synergistically enhances the cytotoxicity of gossypol in DU145 prostate cancer cells: An iTRTAQ-based quantitative proteomic analysis. J Proteomics. 2011, 74: 2180-2193. 10.1016\/j.jprot.2011.06.016.","journal-title":"J Proteomics"},{"key":"610_CR31","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1359\/JBMR.050813","volume":"20","author":"TM Schroeder","year":"2005","unstructured":"Schroeder TM, Westendorf JJ: Histone deacetylase inhibitors promote osteoblast maturation. J Bone Miner Res. 2005, 20: 2254-2263. 10.1359\/JBMR.050813.","journal-title":"J Bone Miner Res"},{"key":"610_CR32","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1515\/JPEM.2011.019","volume":"24","author":"A Aksoy","year":"2011","unstructured":"Aksoy A, Sonmez FM, Deger O, Hosver I, Karaguzel G: The effects of antiepileptic drugs on the relationships between leptin levels and bone turnover in prepubertal children with epilepsy. J Pediatr Endocrinol Metab. 2011, 24: 703-708.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"610_CR33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jns.2009.12.015","volume":"290","author":"N Triantafyllou","year":"2010","unstructured":"Triantafyllou N, Lambrinoudaki I, Armeni E, Evangelopoulos EM, Boufidou F, Antoniou A, Tsivgoulis G: Effect of long-term valproate monotherapy on bone mineral density in adults with epilepsy. J Neurol Sci. 2010, 290: 131-134. 10.1016\/j.jns.2009.12.015.","journal-title":"J Neurol Sci"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-10-101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1741-7015-10-101\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-10-101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T13:00:09Z","timestamp":1643374809000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/1741-7015-10-101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,7]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["610"],"URL":"https:\/\/doi.org\/10.1186\/1741-7015-10-101","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,7]]},"article-number":"101"}}